SNDL Inc.
SNDL Inc. SNDL Peers
See (SNDL) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SNDL | $1.31 | -0.38% | 337.06M | -4.52 | -$0.29 | N/A |
| ZTS | $161.99 | +0.34% | 72.12B | 29.08 | $5.57 | +1.15% |
| HLN | $11.06 | -0.41% | 49.86B | 26.32 | $0.42 | +1.52% |
| TAK | $14.43 | +0.77% | 45.42B | 62.74 | $0.23 | +4.08% |
| TEVA | $16.94 | +2.36% | 19.41B | -14.73 | -$1.15 | N/A |
| ITCI | $131.87 | N/A | 14.05B | -180.64 | -$0.73 | N/A |
| RDY | $14.27 | -0.45% | 11.88B | 18.06 | $0.79 | +0.67% |
| NBIX | $119.12 | -1.19% | 11.79B | 40.38 | $2.95 | N/A |
| CTLT | $63.48 | N/A | 11.52B | -27.84 | -$2.28 | N/A |
| VTRS | $8.50 | +0.24% | 9.98B | -2.67 | -$3.18 | +5.64% |
Stock Comparison
SNDL vs ZTS Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, ZTS has a market cap of 72.12B. Regarding current trading prices, SNDL is priced at $1.31, while ZTS trades at $161.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas ZTS's P/E ratio is 29.08. In terms of profitability, SNDL's ROE is -0.09%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, SNDL is more volatile compared to ZTS. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs HLN Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, HLN has a market cap of 49.86B. Regarding current trading prices, SNDL is priced at $1.31, while HLN trades at $11.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas HLN's P/E ratio is 26.32. In terms of profitability, SNDL's ROE is -0.09%, compared to HLN's ROE of +0.09%. Regarding short-term risk, SNDL is more volatile compared to HLN. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs TAK Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, TAK has a market cap of 45.42B. Regarding current trading prices, SNDL is priced at $1.31, while TAK trades at $14.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas TAK's P/E ratio is 62.74. In terms of profitability, SNDL's ROE is -0.09%, compared to TAK's ROE of +0.04%. Regarding short-term risk, SNDL is more volatile compared to TAK. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs TEVA Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, TEVA has a market cap of 19.41B. Regarding current trading prices, SNDL is priced at $1.31, while TEVA trades at $16.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas TEVA's P/E ratio is -14.73. In terms of profitability, SNDL's ROE is -0.09%, compared to TEVA's ROE of -0.21%. Regarding short-term risk, SNDL is less volatile compared to TEVA. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs ITCI Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, ITCI has a market cap of 14.05B. Regarding current trading prices, SNDL is priced at $1.31, while ITCI trades at $131.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas ITCI's P/E ratio is -180.64. In terms of profitability, SNDL's ROE is -0.09%, compared to ITCI's ROE of -0.07%. Regarding short-term risk, SNDL is more volatile compared to ITCI. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs RDY Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, RDY has a market cap of 11.88B. Regarding current trading prices, SNDL is priced at $1.31, while RDY trades at $14.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas RDY's P/E ratio is 18.06. In terms of profitability, SNDL's ROE is -0.09%, compared to RDY's ROE of +0.18%. Regarding short-term risk, SNDL is more volatile compared to RDY. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs NBIX Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, NBIX has a market cap of 11.79B. Regarding current trading prices, SNDL is priced at $1.31, while NBIX trades at $119.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas NBIX's P/E ratio is 40.38. In terms of profitability, SNDL's ROE is -0.09%, compared to NBIX's ROE of +0.12%. Regarding short-term risk, SNDL is more volatile compared to NBIX. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs CTLT Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, CTLT has a market cap of 11.52B. Regarding current trading prices, SNDL is priced at $1.31, while CTLT trades at $63.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas CTLT's P/E ratio is -27.84. In terms of profitability, SNDL's ROE is -0.09%, compared to CTLT's ROE of -0.11%. Regarding short-term risk, SNDL is more volatile compared to CTLT. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs VTRS Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, VTRS has a market cap of 9.98B. Regarding current trading prices, SNDL is priced at $1.31, while VTRS trades at $8.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas VTRS's P/E ratio is -2.67. In terms of profitability, SNDL's ROE is -0.09%, compared to VTRS's ROE of -0.21%. Regarding short-term risk, SNDL is more volatile compared to VTRS. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs ELAN Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, ELAN has a market cap of 6.29B. Regarding current trading prices, SNDL is priced at $1.31, while ELAN trades at $12.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas ELAN's P/E ratio is 16.90. In terms of profitability, SNDL's ROE is -0.09%, compared to ELAN's ROE of +0.06%. Regarding short-term risk, SNDL is more volatile compared to ELAN. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs RGC Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, RGC has a market cap of 5.74B. Regarding current trading prices, SNDL is priced at $1.31, while RGC trades at $440.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas RGC's P/E ratio is -1422.42. In terms of profitability, SNDL's ROE is -0.09%, compared to RGC's ROE of -0.25%. Regarding short-term risk, SNDL is less volatile compared to RGC. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs LNTH Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, LNTH has a market cap of 5.17B. Regarding current trading prices, SNDL is priced at $1.31, while LNTH trades at $74.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas LNTH's P/E ratio is 21.30. In terms of profitability, SNDL's ROE is -0.09%, compared to LNTH's ROE of +0.23%. Regarding short-term risk, SNDL is more volatile compared to LNTH. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs PRGO Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, PRGO has a market cap of 3.63B. Regarding current trading prices, SNDL is priced at $1.31, while PRGO trades at $26.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas PRGO's P/E ratio is -21.99. In terms of profitability, SNDL's ROE is -0.09%, compared to PRGO's ROE of -0.04%. Regarding short-term risk, SNDL is more volatile compared to PRGO. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs AMRX Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, AMRX has a market cap of 3.35B. Regarding current trading prices, SNDL is priced at $1.31, while AMRX trades at $7.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas AMRX's P/E ratio is -179.75. In terms of profitability, SNDL's ROE is -0.09%, compared to AMRX's ROE of -0.07%. Regarding short-term risk, SNDL is more volatile compared to AMRX. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs ALVOW Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, ALVOW has a market cap of 3.20B. Regarding current trading prices, SNDL is priced at $1.31, while ALVOW trades at $1.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas ALVOW's P/E ratio is N/A. In terms of profitability, SNDL's ROE is -0.09%, compared to ALVOW's ROE of -0.23%. Regarding short-term risk, SNDL is more volatile compared to ALVOW. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs ALVO Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, ALVO has a market cap of 3.00B. Regarding current trading prices, SNDL is priced at $1.31, while ALVO trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas ALVO's P/E ratio is 26.86. In terms of profitability, SNDL's ROE is -0.09%, compared to ALVO's ROE of -0.23%. Regarding short-term risk, SNDL is more volatile compared to ALVO. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs HCM Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, HCM has a market cap of 2.33B. Regarding current trading prices, SNDL is priced at $1.31, while HCM trades at $13.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas HCM's P/E ratio is 66.35. In terms of profitability, SNDL's ROE is -0.09%, compared to HCM's ROE of +0.05%. Regarding short-term risk, SNDL is more volatile compared to HCM. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs DCPH Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, DCPH has a market cap of 2.21B. Regarding current trading prices, SNDL is priced at $1.31, while DCPH trades at $25.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas DCPH's P/E ratio is -11.58. In terms of profitability, SNDL's ROE is -0.09%, compared to DCPH's ROE of -0.52%. Regarding short-term risk, SNDL is more volatile compared to DCPH. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs EMBCV Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, EMBCV has a market cap of 1.91B. Regarding current trading prices, SNDL is priced at $1.31, while EMBCV trades at $33.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas EMBCV's P/E ratio is N/A. In terms of profitability, SNDL's ROE is -0.09%, compared to EMBCV's ROE of -0.07%. Regarding short-term risk, SNDL is less volatile compared to EMBCV. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs BGM Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, BGM has a market cap of 1.87B. Regarding current trading prices, SNDL is priced at $1.31, while BGM trades at $12.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas BGM's P/E ratio is -64.20. In terms of profitability, SNDL's ROE is -0.09%, compared to BGM's ROE of -0.03%. Regarding short-term risk, SNDL is less volatile compared to BGM. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs SUPN Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, SUPN has a market cap of 1.79B. Regarding current trading prices, SNDL is priced at $1.31, while SUPN trades at $32.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas SUPN's P/E ratio is 28.86. In terms of profitability, SNDL's ROE is -0.09%, compared to SUPN's ROE of +0.06%. Regarding short-term risk, SNDL is more volatile compared to SUPN. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs BHC Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, BHC has a market cap of 1.66B. Regarding current trading prices, SNDL is priced at $1.31, while BHC trades at $4.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas BHC's P/E ratio is -37.42. In terms of profitability, SNDL's ROE is -0.09%, compared to BHC's ROE of +0.05%. Regarding short-term risk, SNDL is more volatile compared to BHC. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs TARO Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, TARO has a market cap of 1.62B. Regarding current trading prices, SNDL is priced at $1.31, while TARO trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas TARO's P/E ratio is 30.05. In terms of profitability, SNDL's ROE is -0.09%, compared to TARO's ROE of +0.03%. Regarding short-term risk, SNDL is more volatile compared to TARO. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs EVO Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, EVO has a market cap of 1.43B. Regarding current trading prices, SNDL is priced at $1.31, while EVO trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas EVO's P/E ratio is -6.11. In terms of profitability, SNDL's ROE is -0.09%, compared to EVO's ROE of -0.22%. Regarding short-term risk, SNDL is less volatile compared to EVO. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs INDV Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, INDV has a market cap of 1.40B. Regarding current trading prices, SNDL is priced at $1.31, while INDV trades at $11.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas INDV's P/E ratio is -224.20. In terms of profitability, SNDL's ROE is -0.09%, compared to INDV's ROE of -0.01%. Regarding short-term risk, SNDL is more volatile compared to INDV. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs ANIP Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, ANIP has a market cap of 1.24B. Regarding current trading prices, SNDL is priced at $1.31, while ANIP trades at $57.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas ANIP's P/E ratio is -48.53. In terms of profitability, SNDL's ROE is -0.09%, compared to ANIP's ROE of -0.05%. Regarding short-term risk, SNDL is more volatile compared to ANIP. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs PCRX Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, PCRX has a market cap of 1.21B. Regarding current trading prices, SNDL is priced at $1.31, while PCRX trades at $26.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas PCRX's P/E ratio is -11.64. In terms of profitability, SNDL's ROE is -0.09%, compared to PCRX's ROE of -0.13%. Regarding short-term risk, SNDL is more volatile compared to PCRX. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs DVAX Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, DVAX has a market cap of 1.18B. Regarding current trading prices, SNDL is priced at $1.31, while DVAX trades at $9.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas DVAX's P/E ratio is -19.64. In terms of profitability, SNDL's ROE is -0.09%, compared to DVAX's ROE of -0.10%. Regarding short-term risk, SNDL is more volatile compared to DVAX. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs AMPH Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, AMPH has a market cap of 1.14B. Regarding current trading prices, SNDL is priced at $1.31, while AMPH trades at $24.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas AMPH's P/E ratio is 8.77. In terms of profitability, SNDL's ROE is -0.09%, compared to AMPH's ROE of +0.19%. Regarding short-term risk, SNDL is more volatile compared to AMPH. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs HROW Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, HROW has a market cap of 944.65M. Regarding current trading prices, SNDL is priced at $1.31, while HROW trades at $25.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas HROW's P/E ratio is -42.20. In terms of profitability, SNDL's ROE is -0.09%, compared to HROW's ROE of -0.36%. Regarding short-term risk, SNDL is less volatile compared to HROW. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs PAHC Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, PAHC has a market cap of 933.08M. Regarding current trading prices, SNDL is priced at $1.31, while PAHC trades at $23.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas PAHC's P/E ratio is 29.51. In terms of profitability, SNDL's ROE is -0.09%, compared to PAHC's ROE of +0.12%. Regarding short-term risk, SNDL is more volatile compared to PAHC. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs COLL Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, COLL has a market cap of 926.34M. Regarding current trading prices, SNDL is priced at $1.31, while COLL trades at $28.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas COLL's P/E ratio is 23.62. In terms of profitability, SNDL's ROE is -0.09%, compared to COLL's ROE of +0.19%. Regarding short-term risk, SNDL is more volatile compared to COLL. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs PETQ Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, PETQ has a market cap of 919.17M. Regarding current trading prices, SNDL is priced at $1.31, while PETQ trades at $30.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas PETQ's P/E ratio is 83.73. In terms of profitability, SNDL's ROE is -0.09%, compared to PETQ's ROE of +0.06%. Regarding short-term risk, SNDL is more volatile compared to PETQ. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs AVDL Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, AVDL has a market cap of 859.04M. Regarding current trading prices, SNDL is priced at $1.31, while AVDL trades at $8.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas AVDL's P/E ratio is -34.15. In terms of profitability, SNDL's ROE is -0.09%, compared to AVDL's ROE of -0.36%. Regarding short-term risk, SNDL is less volatile compared to AVDL. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs CRON Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, CRON has a market cap of 790.11M. Regarding current trading prices, SNDL is priced at $1.31, while CRON trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas CRON's P/E ratio is 14.64. In terms of profitability, SNDL's ROE is -0.09%, compared to CRON's ROE of +0.05%. Regarding short-term risk, SNDL is more volatile compared to CRON. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs EOLS Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, EOLS has a market cap of 616.39M. Regarding current trading prices, SNDL is priced at $1.31, while EOLS trades at $9.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas EOLS's P/E ratio is -10.74. In terms of profitability, SNDL's ROE is -0.09%, compared to EOLS's ROE of -9.32%. Regarding short-term risk, SNDL is more volatile compared to EOLS. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs EMBC Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, EMBC has a market cap of 613.94M. Regarding current trading prices, SNDL is priced at $1.31, while EMBC trades at $10.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas EMBC's P/E ratio is 11.80. In terms of profitability, SNDL's ROE is -0.09%, compared to EMBC's ROE of -0.07%. Regarding short-term risk, SNDL is less volatile compared to EMBC. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs BDSI Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, BDSI has a market cap of 577.05M. Regarding current trading prices, SNDL is priced at $1.31, while BDSI trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas BDSI's P/E ratio is 6.82. In terms of profitability, SNDL's ROE is -0.09%, compared to BDSI's ROE of +0.57%. Regarding short-term risk, SNDL is more volatile compared to BDSI. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs ZYBT Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, ZYBT has a market cap of 461.12M. Regarding current trading prices, SNDL is priced at $1.31, while ZYBT trades at $9.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas ZYBT's P/E ratio is 162.17. In terms of profitability, SNDL's ROE is -0.09%, compared to ZYBT's ROE of +0.11%. Regarding short-term risk, SNDL is less volatile compared to ZYBT. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs TLRY Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, TLRY has a market cap of 458.41M. Regarding current trading prices, SNDL is priced at $1.31, while TLRY trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas TLRY's P/E ratio is -0.41. In terms of profitability, SNDL's ROE is -0.09%, compared to TLRY's ROE of -0.29%. Regarding short-term risk, SNDL is less volatile compared to TLRY. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs SIGA Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, SIGA has a market cap of 417.22M. Regarding current trading prices, SNDL is priced at $1.31, while SIGA trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas SIGA's P/E ratio is 8.72. In terms of profitability, SNDL's ROE is -0.09%, compared to SIGA's ROE of +0.25%. Regarding short-term risk, SNDL is less volatile compared to SIGA. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs KMDA Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, KMDA has a market cap of 387.58M. Regarding current trading prices, SNDL is priced at $1.31, while KMDA trades at $6.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas KMDA's P/E ratio is 24.07. In terms of profitability, SNDL's ROE is -0.09%, compared to KMDA's ROE of +0.06%. Regarding short-term risk, SNDL is more volatile compared to KMDA. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs ORGO Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, ORGO has a market cap of 376.76M. Regarding current trading prices, SNDL is priced at $1.31, while ORGO trades at $2.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas ORGO's P/E ratio is -18.56. In terms of profitability, SNDL's ROE is -0.09%, compared to ORGO's ROE of -0.06%. Regarding short-term risk, SNDL is more volatile compared to ORGO. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs EBS Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, EBS has a market cap of 353.35M. Regarding current trading prices, SNDL is priced at $1.31, while EBS trades at $6.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas EBS's P/E ratio is -2.52. In terms of profitability, SNDL's ROE is -0.09%, compared to EBS's ROE of -0.27%. Regarding short-term risk, SNDL is more volatile compared to EBS. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs CGC Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, CGC has a market cap of 347.56M. Regarding current trading prices, SNDL is priced at $1.31, while CGC trades at $1.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas CGC's P/E ratio is -0.53. In terms of profitability, SNDL's ROE is -0.09%, compared to CGC's ROE of -0.88%. Regarding short-term risk, SNDL is less volatile compared to CGC. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs TKNO Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, TKNO has a market cap of 332.94M. Regarding current trading prices, SNDL is priced at $1.31, while TKNO trades at $6.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas TKNO's P/E ratio is -13.54. In terms of profitability, SNDL's ROE is -0.09%, compared to TKNO's ROE of -0.28%. Regarding short-term risk, SNDL is less volatile compared to TKNO. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs ACB Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, ACB has a market cap of 301.31M. Regarding current trading prices, SNDL is priced at $1.31, while ACB trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas ACB's P/E ratio is 28.89. In terms of profitability, SNDL's ROE is -0.09%, compared to ACB's ROE of -0.06%. Regarding short-term risk, SNDL is less volatile compared to ACB. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs ALIM Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, ALIM has a market cap of 301.29M. Regarding current trading prices, SNDL is priced at $1.31, while ALIM trades at $5.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas ALIM's P/E ratio is 5.28. In terms of profitability, SNDL's ROE is -0.09%, compared to ALIM's ROE of -0.34%. Regarding short-term risk, SNDL is more volatile compared to ALIM. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs LNDC Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, LNDC has a market cap of 263.63M. Regarding current trading prices, SNDL is priced at $1.31, while LNDC trades at $8.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas LNDC's P/E ratio is -4.04. In terms of profitability, SNDL's ROE is -0.09%, compared to LNDC's ROE of +2.28%. Regarding short-term risk, SNDL is more volatile compared to LNDC. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs LFCR Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, LFCR has a market cap of 246.96M. Regarding current trading prices, SNDL is priced at $1.31, while LFCR trades at $6.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas LFCR's P/E ratio is -4.54. In terms of profitability, SNDL's ROE is -0.09%, compared to LFCR's ROE of -2.64%. Regarding short-term risk, SNDL is less volatile compared to LFCR. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs TYHT Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, TYHT has a market cap of 229.17M. Regarding current trading prices, SNDL is priced at $1.31, while TYHT trades at $11.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas TYHT's P/E ratio is -1.61. In terms of profitability, SNDL's ROE is -0.09%, compared to TYHT's ROE of -1.41%. Regarding short-term risk, SNDL is less volatile compared to TYHT. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs AQST Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, AQST has a market cap of 227.46M. Regarding current trading prices, SNDL is priced at $1.31, while AQST trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas AQST's P/E ratio is -3.95. In terms of profitability, SNDL's ROE is -0.09%, compared to AQST's ROE of +1.07%. Regarding short-term risk, SNDL is less volatile compared to AQST. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs OGI Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, OGI has a market cap of 183.36M. Regarding current trading prices, SNDL is priced at $1.31, while OGI trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas OGI's P/E ratio is 10.54. In terms of profitability, SNDL's ROE is -0.09%, compared to OGI's ROE of +0.05%. Regarding short-term risk, SNDL is less volatile compared to OGI. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs REPH Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, REPH has a market cap of 177.42M. Regarding current trading prices, SNDL is priced at $1.31, while REPH trades at $2.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas REPH's P/E ratio is -8.04. In terms of profitability, SNDL's ROE is -0.09%, compared to REPH's ROE of -0.15%. Regarding short-term risk, SNDL is less volatile compared to REPH. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs ESPR Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, ESPR has a market cap of 159.15M. Regarding current trading prices, SNDL is priced at $1.31, while ESPR trades at $0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas ESPR's P/E ratio is -0.94. In terms of profitability, SNDL's ROE is -0.09%, compared to ESPR's ROE of +0.40%. Regarding short-term risk, SNDL is less volatile compared to ESPR. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs DERM Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, DERM has a market cap of 158.88M. Regarding current trading prices, SNDL is priced at $1.31, while DERM trades at $6.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas DERM's P/E ratio is -18.43. In terms of profitability, SNDL's ROE is -0.09%, compared to DERM's ROE of -0.52%. Regarding short-term risk, SNDL is more volatile compared to DERM. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs BIOA Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, BIOA has a market cap of 144.83M. Regarding current trading prices, SNDL is priced at $1.31, while BIOA trades at $4.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas BIOA's P/E ratio is -2.04. In terms of profitability, SNDL's ROE is -0.09%, compared to BIOA's ROE of -0.38%. Regarding short-term risk, SNDL is less volatile compared to BIOA. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs THTX Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, THTX has a market cap of 119.09M. Regarding current trading prices, SNDL is priced at $1.31, while THTX trades at $2.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas THTX's P/E ratio is -37.00. In terms of profitability, SNDL's ROE is -0.09%, compared to THTX's ROE of +0.16%. Regarding short-term risk, SNDL is more volatile compared to THTX. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs SCTL Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, SCTL has a market cap of 116.13M. Regarding current trading prices, SNDL is priced at $1.31, while SCTL trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas SCTL's P/E ratio is -7.86. In terms of profitability, SNDL's ROE is -0.09%, compared to SCTL's ROE of -0.15%. Regarding short-term risk, SNDL is more volatile compared to SCTL. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs PROC Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, PROC has a market cap of 113.95M. Regarding current trading prices, SNDL is priced at $1.31, while PROC trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas PROC's P/E ratio is 1.53. In terms of profitability, SNDL's ROE is -0.09%, compared to PROC's ROE of -2.22%. Regarding short-term risk, SNDL is more volatile compared to PROC. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs IRWD Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, IRWD has a market cap of 100.34M. Regarding current trading prices, SNDL is priced at $1.31, while IRWD trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas IRWD's P/E ratio is -3.26. In terms of profitability, SNDL's ROE is -0.09%, compared to IRWD's ROE of +0.10%. Regarding short-term risk, SNDL is less volatile compared to IRWD. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs OPTN Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, OPTN has a market cap of 97.22M. Regarding current trading prices, SNDL is priced at $1.31, while OPTN trades at $9.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas OPTN's P/E ratio is -4.42. In terms of profitability, SNDL's ROE is -0.09%, compared to OPTN's ROE of +0.64%. Regarding short-term risk, SNDL is more volatile compared to OPTN. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs ZOM Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, ZOM has a market cap of 95.35M. Regarding current trading prices, SNDL is priced at $1.31, while ZOM trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas ZOM's P/E ratio is -1.62. In terms of profitability, SNDL's ROE is -0.09%, compared to ZOM's ROE of -0.55%. Regarding short-term risk, SNDL is less volatile compared to ZOM. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs GRVI Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, GRVI has a market cap of 88.91M. Regarding current trading prices, SNDL is priced at $1.31, while GRVI trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas GRVI's P/E ratio is 26.05. In terms of profitability, SNDL's ROE is -0.09%, compared to GRVI's ROE of -5.25%. Regarding short-term risk, SNDL is less volatile compared to GRVI. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs CRDL Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, CRDL has a market cap of 88.41M. Regarding current trading prices, SNDL is priced at $1.31, while CRDL trades at $1.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas CRDL's P/E ratio is -3.15. In terms of profitability, SNDL's ROE is -0.09%, compared to CRDL's ROE of -2.08%. Regarding short-term risk, SNDL is less volatile compared to CRDL. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs CPIX Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, CPIX has a market cap of 76.15M. Regarding current trading prices, SNDL is priced at $1.31, while CPIX trades at $5.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas CPIX's P/E ratio is -21.21. In terms of profitability, SNDL's ROE is -0.09%, compared to CPIX's ROE of -0.13%. Regarding short-term risk, SNDL is less volatile compared to CPIX. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs INCR Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, INCR has a market cap of 73.48M. Regarding current trading prices, SNDL is priced at $1.31, while INCR trades at $1.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas INCR's P/E ratio is -3.89. In terms of profitability, SNDL's ROE is -0.09%, compared to INCR's ROE of -0.07%. Regarding short-term risk, SNDL is less volatile compared to INCR. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs ZYNE Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, ZYNE has a market cap of 70.12M. Regarding current trading prices, SNDL is priced at $1.31, while ZYNE trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas ZYNE's P/E ratio is -1.65. In terms of profitability, SNDL's ROE is -0.09%, compared to ZYNE's ROE of -0.59%. Regarding short-term risk, SNDL is less volatile compared to ZYNE. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs ASRT Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, ASRT has a market cap of 68.03M. Regarding current trading prices, SNDL is priced at $1.31, while ASRT trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas ASRT's P/E ratio is -2.22. In terms of profitability, SNDL's ROE is -0.09%, compared to ASRT's ROE of -0.24%. Regarding short-term risk, SNDL is less volatile compared to ASRT. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs SSIC Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, SSIC has a market cap of 66.72M. Regarding current trading prices, SNDL is priced at $1.31, while SSIC trades at $10.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas SSIC's P/E ratio is 11.93. In terms of profitability, SNDL's ROE is -0.09%, compared to SSIC's ROE of +0.03%. Regarding short-term risk, SNDL is more volatile compared to SSIC. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs VLNS Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, VLNS has a market cap of 61.46M. Regarding current trading prices, SNDL is priced at $1.31, while VLNS trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas VLNS's P/E ratio is -1.03. In terms of profitability, SNDL's ROE is -0.09%, compared to VLNS's ROE of N/A. Regarding short-term risk, SNDL is less volatile compared to VLNS. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs JUPW Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, JUPW has a market cap of 49.33M. Regarding current trading prices, SNDL is priced at $1.31, while JUPW trades at $1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas JUPW's P/E ratio is -2.41. In terms of profitability, SNDL's ROE is -0.09%, compared to JUPW's ROE of -9.40%. Regarding short-term risk, SNDL is less volatile compared to JUPW. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs QLI Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, QLI has a market cap of 38.68M. Regarding current trading prices, SNDL is priced at $1.31, while QLI trades at $5.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas QLI's P/E ratio is -4.92. In terms of profitability, SNDL's ROE is -0.09%, compared to QLI's ROE of -0.16%. Regarding short-term risk, SNDL is more volatile compared to QLI. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs RMTI Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, RMTI has a market cap of 34.06M. Regarding current trading prices, SNDL is priced at $1.31, while RMTI trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas RMTI's P/E ratio is -99.67. In terms of profitability, SNDL's ROE is -0.09%, compared to RMTI's ROE of -0.01%. Regarding short-term risk, SNDL is less volatile compared to RMTI. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs HEXO Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, HEXO has a market cap of 31.24M. Regarding current trading prices, SNDL is priced at $1.31, while HEXO trades at $0.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas HEXO's P/E ratio is -0.26. In terms of profitability, SNDL's ROE is -0.09%, compared to HEXO's ROE of -2.06%. Regarding short-term risk, SNDL is less volatile compared to HEXO. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs SCYX Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, SCYX has a market cap of 30.04M. Regarding current trading prices, SNDL is priced at $1.31, while SCYX trades at $0.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas SCYX's P/E ratio is -1.37. In terms of profitability, SNDL's ROE is -0.09%, compared to SCYX's ROE of -0.48%. Regarding short-term risk, SNDL is less volatile compared to SCYX. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs QNTM Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, QNTM has a market cap of 28.10M. Regarding current trading prices, SNDL is priced at $1.31, while QNTM trades at $12.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas QNTM's P/E ratio is -0.92. In terms of profitability, SNDL's ROE is -0.09%, compared to QNTM's ROE of -1.88%. Regarding short-term risk, SNDL is less volatile compared to QNTM. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs SXTC Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, SXTC has a market cap of 25.80M. Regarding current trading prices, SNDL is priced at $1.31, while SXTC trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas SXTC's P/E ratio is 0.01. In terms of profitability, SNDL's ROE is -0.09%, compared to SXTC's ROE of +0.47%. Regarding short-term risk, SNDL is less volatile compared to SXTC. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs KALA Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, KALA has a market cap of 25.55M. Regarding current trading prices, SNDL is priced at $1.31, while KALA trades at $3.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas KALA's P/E ratio is -0.54. In terms of profitability, SNDL's ROE is -0.09%, compared to KALA's ROE of -3.69%. Regarding short-term risk, SNDL is less volatile compared to KALA. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs CYTH Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, CYTH has a market cap of 23.59M. Regarding current trading prices, SNDL is priced at $1.31, while CYTH trades at $0.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas CYTH's P/E ratio is -0.80. In terms of profitability, SNDL's ROE is -0.09%, compared to CYTH's ROE of +7.50%. Regarding short-term risk, SNDL is more volatile compared to CYTH. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs EGRX Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, EGRX has a market cap of 23.32M. Regarding current trading prices, SNDL is priced at $1.31, while EGRX trades at $1.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas EGRX's P/E ratio is 2.12. In terms of profitability, SNDL's ROE is -0.09%, compared to EGRX's ROE of +0.17%. Regarding short-term risk, SNDL is more volatile compared to EGRX. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs GELS Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, GELS has a market cap of 17.46M. Regarding current trading prices, SNDL is priced at $1.31, while GELS trades at $1.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas GELS's P/E ratio is -7.71. In terms of profitability, SNDL's ROE is -0.09%, compared to GELS's ROE of -0.21%. Regarding short-term risk, SNDL is more volatile compared to GELS. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs DRRX Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, DRRX has a market cap of 16.89M. Regarding current trading prices, SNDL is priced at $1.31, while DRRX trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas DRRX's P/E ratio is -1.13. In terms of profitability, SNDL's ROE is -0.09%, compared to DRRX's ROE of -0.93%. Regarding short-term risk, SNDL is less volatile compared to DRRX. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs TXMD Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, TXMD has a market cap of 16.78M. Regarding current trading prices, SNDL is priced at $1.31, while TXMD trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas TXMD's P/E ratio is -7.63. In terms of profitability, SNDL's ROE is -0.09%, compared to TXMD's ROE of -0.08%. Regarding short-term risk, SNDL is less volatile compared to TXMD. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs FLGC Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, FLGC has a market cap of 15.35M. Regarding current trading prices, SNDL is priced at $1.31, while FLGC trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas FLGC's P/E ratio is -0.71. In terms of profitability, SNDL's ROE is -0.09%, compared to FLGC's ROE of -2.55%. Regarding short-term risk, SNDL is less volatile compared to FLGC. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs ACRX Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, ACRX has a market cap of 14.58M. Regarding current trading prices, SNDL is priced at $1.31, while ACRX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas ACRX's P/E ratio is -0.31. In terms of profitability, SNDL's ROE is -0.09%, compared to ACRX's ROE of -2.49%. Regarding short-term risk, SNDL is less volatile compared to ACRX. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs SISI Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, SISI has a market cap of 14.35M. Regarding current trading prices, SNDL is priced at $1.31, while SISI trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas SISI's P/E ratio is N/A. In terms of profitability, SNDL's ROE is -0.09%, compared to SISI's ROE of -1.41%. Regarding short-term risk, SNDL is less volatile compared to SISI. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs PRPH Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, PRPH has a market cap of 12.86M. Regarding current trading prices, SNDL is priced at $1.31, while PRPH trades at $0.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas PRPH's P/E ratio is -0.14. In terms of profitability, SNDL's ROE is -0.09%, compared to PRPH's ROE of -1.59%. Regarding short-term risk, SNDL is less volatile compared to PRPH. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs COSM Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, COSM has a market cap of 12.73M. Regarding current trading prices, SNDL is priced at $1.31, while COSM trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas COSM's P/E ratio is -0.41. In terms of profitability, SNDL's ROE is -0.09%, compared to COSM's ROE of -0.51%. Regarding short-term risk, SNDL is less volatile compared to COSM. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs AYTU Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, AYTU has a market cap of 12.46M. Regarding current trading prices, SNDL is priced at $1.31, while AYTU trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas AYTU's P/E ratio is -1.36. In terms of profitability, SNDL's ROE is -0.09%, compared to AYTU's ROE of +0.05%. Regarding short-term risk, SNDL is more volatile compared to AYTU. This indicates potentially higher risk in terms of short-term price fluctuations for SNDL.
SNDL vs AGRX Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, AGRX has a market cap of 10.43M. Regarding current trading prices, SNDL is priced at $1.31, while AGRX trades at $1.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas AGRX's P/E ratio is -0.89. In terms of profitability, SNDL's ROE is -0.09%, compared to AGRX's ROE of +1.04%. Regarding short-term risk, SNDL is less volatile compared to AGRX. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs TLPH Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, TLPH has a market cap of 10.33M. Regarding current trading prices, SNDL is priced at $1.31, while TLPH trades at $0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas TLPH's P/E ratio is -1.15. In terms of profitability, SNDL's ROE is -0.09%, compared to TLPH's ROE of -1.29%. Regarding short-term risk, SNDL is less volatile compared to TLPH. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs YCBD Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, YCBD has a market cap of 8.28M. Regarding current trading prices, SNDL is priced at $1.31, while YCBD trades at $0.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas YCBD's P/E ratio is 0.01. In terms of profitability, SNDL's ROE is -0.09%, compared to YCBD's ROE of -8.81%. Regarding short-term risk, SNDL is less volatile compared to YCBD. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs NLTX Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, NLTX has a market cap of 8.20M. Regarding current trading prices, SNDL is priced at $1.31, while NLTX trades at $3.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas NLTX's P/E ratio is -0.28. In terms of profitability, SNDL's ROE is -0.09%, compared to NLTX's ROE of -0.49%. Regarding short-term risk, SNDL is less volatile compared to NLTX. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs CPHI Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, CPHI has a market cap of 7.44M. Regarding current trading prices, SNDL is priced at $1.31, while CPHI trades at $2.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas CPHI's P/E ratio is -1.03. In terms of profitability, SNDL's ROE is -0.09%, compared to CPHI's ROE of -0.45%. Regarding short-term risk, SNDL is less volatile compared to CPHI. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs SBFMW Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, SBFMW has a market cap of 7.40M. Regarding current trading prices, SNDL is priced at $1.31, while SBFMW trades at $0.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas SBFMW's P/E ratio is -0.11. In terms of profitability, SNDL's ROE is -0.09%, compared to SBFMW's ROE of -0.21%. Regarding short-term risk, SNDL is less volatile compared to SBFMW. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs LCI Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, LCI has a market cap of 7.38M. Regarding current trading prices, SNDL is priced at $1.31, while LCI trades at $0.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas LCI's P/E ratio is -0.04. In terms of profitability, SNDL's ROE is -0.09%, compared to LCI's ROE of +1.66%. Regarding short-term risk, SNDL is less volatile compared to LCI. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs BGXX Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, BGXX has a market cap of 7.26M. Regarding current trading prices, SNDL is priced at $1.31, while BGXX trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas BGXX's P/E ratio is -0.76. In terms of profitability, SNDL's ROE is -0.09%, compared to BGXX's ROE of -0.88%. Regarding short-term risk, SNDL is less volatile compared to BGXX. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.
SNDL vs ADMP Comparison
SNDL plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SNDL stands at 337.06M. In comparison, ADMP has a market cap of 7.25M. Regarding current trading prices, SNDL is priced at $1.31, while ADMP trades at $0.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SNDL currently has a P/E ratio of -4.52, whereas ADMP's P/E ratio is -0.08. In terms of profitability, SNDL's ROE is -0.09%, compared to ADMP's ROE of +0.00%. Regarding short-term risk, SNDL is less volatile compared to ADMP. This indicates potentially lower risk in terms of short-term price fluctuations for SNDL.